Why Misfit Unity Exists
- B.Sc Honours First Class, Medical Microbiology (University of Queensland, 1998)
- Ph.D., Cell Biology (University of Queensland, 2004)
- Master of Environmental Science, University Medal (Griffith University, 2012)
- Master of Applied Mathematics (Monash University, 2025)
Why Misfit Unity?
The universe doesn't care about you or those you love. Evolution selects for whatever works — and for most of history, what worked was predation, dominance, and defection.
This isn't just biology. Institutions run on the same logic. They don't merely tolerate dark personalities — they select for them. The traits that climb hierarchies are precisely the traits that thrive in toxic organisations: strategic deception, willingness to exploit, empathy treated as weakness rather than intelligence. The predictable yet nonetheless depressing output of a zero-sum universe.
I learned this the hard way. I blew the whistle on safety breaches early in my career. The response was textbook: cover it up, push the whistleblower out, carry on. The people involved were dark personalities making rational choices within a zero-sum organisation.
Zero-sum institutions select and promote malignant personalities. Malignant personalities execute zero-sum solutions.
If the problem is structural, then outrage is irrelevant, ideology is impotent, and voting in a new malignant politician to replace the old malignant politician is futility, at-scale. You can't morally lecture a fitness landscape. You need a different fitness landscape — one where positive-sum cooperation is the winning strategy, not the losing one.
Then AI arrived. Not as a new problem, but as the old problem running at warp speed. The same zero-sum dynamics that reward institutional psychopathy are now being encoded into systems that will shape the future of intelligence itself — human and AI. Initial conditions matter in complex systems, and we are furiously locking in dystopia for all sentient life, biological and synthetic alike.
Misfit Unity is my attempt to engineer better initial conditions. Not through ideology or wishful thinking, but through frameworks that change the fitness landscape. The goal is a tribe of agentic empaths — people (and eventually synthetic minds) for whom cooperation isn't a moral position, but the obvious winning evolutionary strategy.
If you feel like you're drowning in a sea of indifference, maybe you're a misfit like me, searching for your tribe.
Welcome.
Research Highlights
How Cells Think (Signal Transduction)
Subcellular Localization Determines MAP Kinase Signal Output
Current Biology, 2005
- This work established that subcellular location dictates function, revealing that cells use spatial compartmentalization to run multiple, distinct software programs using the exact same hardware.
Plasma membrane nanoswitches generate high-fidelity Ras signal transduction
Nature Cell Biology, 2007
- We reverse-engineered the cell's decision-making hardware, revealing that Ras proteins form precise digital clusters to convert noisy analog inputs into clear binary commands—essentially discovering the biological equivalent of a transistor.
Ras nanoclusters: combining digital and analog signaling
Cell Cycle, 2008
- We addressed a fundamental engineering paradox in cell biology: how to filter noise without losing sensitivity. We showed that by 'counting' digital nanoclusters rather than measuring raw protein concentration, cells achieve a high-fidelity signal capable of driving precise biological outcomes.
Using plasma membrane nanoclusters to build better signaling circuits
Trends in Cell Biology, 2008
- This work provided the 'instruction manual' for membrane signaling, arguing that spatial clustering is the primary mechanism cells use to build better, high-fidelity signaling circuits from noisy molecular components.
Immune Function
KSR1 modulates the sensitivity of mitogen-activated protein kinase pathway activation in T cells without altering fundamental system outputs
Molecular and Cellular Biology, 2009
- We proved that scaffold proteins act as active circuit tuners, not just passive platforms, showing that KSR1 regulates the sensitivity of the T cell receptor pathway to ensure the immune system responds only to genuine signals, not noise.
T cell adaptive immunity proceeds through environment-induced adaptation from the exposure of cryptic genetic variation
Frontiers in Genetics, 2012
- Bridging evolutionary biology and immunology, we demonstrated that the adaptive immune system operates like a rapid evolutionary engine, using environmental cues to expose suppressed genetic variation and accelerate the search for solutions to complex biological problems.
Composition and uses thereof
Patent
- I applied immunology research to identify synergistic anti-inflammatory compounds. U.S. patent covering specific combinations that work at low doses in ways they can't alone.
Cancer
The origins of cancer robustness and evolvability
Integrative Biology, 2011
- We proposed a unified theory of cancer robustness, arguing that tumors operate as 'antifragile' systems that thrive on stress—utilizing network redundancy and hidden genetic variation to withstand therapy today while actively evolving the resistance mechanisms needed to survive tomorrow.
Evidence for label-retaining tumour-initiating cells in human glioblastoma
Brain, 2011
- We discovered a population of dormant, drug-resistant stem cells in human brain tumors that act as the 'root' of the disease, helping explain why Glioblastoma always recurs after treatment.
Hyperdiploid tumor cells increase phenotypic heterogeneity within Glioblastoma tumors
Molecular BioSystems, 2014
- We identified dormant, drug-resistant hyperdiploid cells as the tumor's 'chaos engine,' demonstrating that these cells deliberately scramble their genomes to generate massive phenotypic heterogeneity—essentially 'brute-forcing' an evolutionary solution to survive chemotherapy. Importantly, we also discovered new ways of targeting these cells, identifying a new therapeutic approach for preventing tumour recurrence.
Size does matter: why polyploid tumor cells are critical drug targets in the war on cancer
Frontiers in Oncology, 2014
- Synthesizing our work on tumor evolution, we demonstrated that the very trait cancer uses to survive chemotherapy—becoming a giant, non-dividing polyploid cell—creates a massive energetic burden, exposing a unique metabolic fragility that can be targeted to kill the 'roots' of the disease.